# FDA 483 - Siddha Flower Essences - April 29, 2025

Source: https://www.keypedia.com/records/483/siddha-flower-essences/3303234a-e593-4139-b455-df9e234a77cd

> FDA 483 for Siddha Flower Essences on April 29, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Siddha Flower Essences
- Inspection Date: 2025-04-29
- Product Type: drugs
- Office Name: Los Angeles District Office
- Summary: Siddha Flower Essences, LLC, a homeopathic drug manufacturer in Oxnard, CA, was cited for significant deficiencies across its quality control, production, and testing processes. The inspection revealed failures in finished product testing, OOS investigations, process validation, component reliability verification, and batch record completeness. These issues indicate a lack of adequate controls to ensure the quality and purity of their OTC homeopathic drug products.

## Related Documents

- [WARNING_LETTER - 2025-04-29](https://www.keypedia.com/records/warning_letter/siddha-flower-essences/c9f87479-b635-4458-a8c2-8695377fd5b2)

## Related Officers

- [Crystal Monroy](https://www.keypedia.com/people/crystal-monroy/b0414886-fb71-4f35-a453-0ad2baf13bfc)

Company: https://www.keypedia.com/companies/siddha-flower-essences/ed2749d5-e487-4341-bfff-eb97b1c87303

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b